Latest BRAIDWELL LP Stock Portfolio

$2.70Billion | No. of Holdings #83

BRAIDWELL LP Performance

2026 Q2+17.86%
YTD+15.80%
2025+5.32%

About BRAIDWELL LP and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, BRAIDWELL LP reported an equity portfolio of $2.7 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of BRAIDWELL LP are , , GKOS. The fund has invested 5.4% of it's portfolio in CARIS LIFE SCIENCES INC and 4.1% of portfolio in HINGE HEALTH INC. <br><br> The fund managers got completely rid off CENTESSA PHARMACEUTICALS PLC (CNTA), NUVALENT INC (NUVL) and CG ONCOLOGY INC stocks. They significantly reduced their stock positions in ARGENX SE (ARGX), GUARDANT HEALTH INC (GH) and CELLDEX THERAPEUTICS INC NEW (CLDX). BRAIDWELL LP opened new stock positions in HUMANA INC (HUM), MAZE THERAPEUTICS INC and AVALO THERAPEUTICS INC (AVTX). The fund showed a lot of confidence in some stocks as they added substantially to REPLIGEN CORP (RGEN), ALPHATEC HLDGS INC (ATEC) and NEKTAR THERAPEUTICS (NKTR).
BRAIDWELL LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$2.70Billion
  as of Aug 14, 2026

BRAIDWELL LP Annual Return Estimates Vs S&P 500

Our best estimate is that BRAIDWELL LP made a return of 17.86% in the last quarter. In trailing 12 months, it's portfolio return was 37.42%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
humana inc45,481,700
maze therapeutics inc34,018,800
avalo therapeutics inc30,107,300
alamar biosciences inc29,365,100
oruka therapeutics inc26,472,900
avalyn pharmaceuticals inc26,381,900
immunocore hldgs plc16,552,100
ovid therapeutics inc15,923,400

New stocks bought by BRAIDWELL LP

Reductions

Ticker% Reduced
repligen corp-84.16
neogenomics inc-82.06
argenx se-79.15
guardant health inc-70.41
celldex therapeutics inc new-67.8
mbx biosciences inc-52.37
neurocrine biosciences inc-48.45
dyne therapeutics inc-45.21

BRAIDWELL LP reduced stake in above stock

Sold off

Ticker$ Sold
guardant health inc-102,576,000
zenas biopharma inc-13,455,000
fulcrum therapeutics inc-24,044,900
engene holdings inc-16,731,300
arrowhead pharmaceuticals in-2,333,480
centessa pharmaceuticals plc-78,914,400
compass therapeutics inc-10,395,400
cg oncology inc-66,650,100

BRAIDWELL LP got rid off the above stocks

Sector Distribution

BRAIDWELL LP has about 69.7% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare69.7
Others30.3

Market Cap. Distribution

BRAIDWELL LP has about 12.8% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
  • MEGA-CAP
Category%
MID-CAP33
UNALLOCATED30.3
SMALL-CAP20.8
LARGE-CAP11.1
MICRO-CAP3
MEGA-CAP1.7

Stocks belong to which Index?

About 46.1% of the stocks held by BRAIDWELL LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others53.9
RUSSELL 200038.9
S&P 5007.2
Top 5 Winners (%)%
MRVI
maravai lifesciences hldgs i
111.5 %
hinge health inc
110.3 %
NEO
neogenomics inc
90.6 %
AGLE
spyre therapeutics inc
73.8 %
EOLS
evolus inc
67.9 %
Top 5 Winners ($)$
hinge health inc
61.9 M
NEO
neogenomics inc
37.8 M
AGLE
spyre therapeutics inc
34.7 M
MRVI
maravai lifesciences hldgs i
32.3 M
mbx biosciences inc
27.9 M
Top 5 Losers (%)%
TMDX
transmedics group inc
-27.7 %
BSX
boston scientific corp
-27.2 %
ATEC
alphatec hldgs inc
-14.7 %
ORIC
oric pharmaceuticals inc
-14.1 %
INSP
inspire med sys inc
-13.5 %
Top 5 Losers ($)$
TMDX
transmedics group inc
-15.5 M
ATEC
alphatec hldgs inc
-9.7 M
BSX
boston scientific corp
-9.4 M
INSP
inspire med sys inc
-4.7 M
ISRG
intuitive surgical inc
-4.7 M

BRAIDWELL LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BRAIDWELL LP

BRAIDWELL LP has 83 stocks in it's portfolio. About 31.3% of the portfolio is in top 10 stocks. TMDX proved to be the most loss making stock for the portfolio. was the most profitable stock for BRAIDWELL LP last quarter.

$2.70BTotal Value
112Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of BRAIDWELL LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ARGX
Argenx Se

Argenx Se

ARGX
BRAIDWELL LP's holding in Argenx Se over time
0.61%17,707
$16.43M
0.61%
decreased 79.15 percentreduced